Ajjan RA - Search Results

1

A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control.

Parker WAE, Sagar R, Kurdee Z, Hawkins F, Naseem KM, Grant PJ, Storey RF, Ajjan RA. Parker WAE, et al. Among authors: ajjan ra. Cardiovasc Diabetol. 2021 Dec 17;20(1):238. doi: 10.1186/s12933-021-01427-y. Cardiovasc Diabetol. 2021. PMID: 34920734 Free PMC article. Clinical Trial.

2

Role of clotting factors and fibrin structure in predisposition to atherothrombotic disease.

Ajjan RA, Grant PJ. Ajjan RA, et al. Expert Rev Cardiovasc Ther. 2005 Nov;3(6):1047-59. doi: 10.1586/14779072.3.6.1047. Expert Rev Cardiovasc Ther. 2005. PMID: 16292996 Review.

3

Coagulation and atherothrombotic disease.

Ajjan R, Grant PJ. Ajjan R, et al. Atherosclerosis. 2006 Jun;186(2):240-59. doi: 10.1016/j.atherosclerosis.2005.10.042. Epub 2005 Dec 15. Atherosclerosis. 2006. PMID: 16343508 Review.

4

Complement C3 and C-reactive protein levels in patients with stable coronary artery disease.

Ajjan R, Grant PJ, Futers TS, Brown JM, Cymbalista CM, Boothby M, Carter AM. Ajjan R, et al. Thromb Haemost. 2005 Nov;94(5):1048-53. doi: 10.1160/TH05-06-0384. Thromb Haemost. 2005. PMID: 16363249

5

The association of complement C3 genotype with coronary artery disease, markers of the metabolic syndrome and C3 plasma levels.

Ajjan RA, Grant PJ, Futers TS, Brown JM, Carter AM. Ajjan RA, et al. Thromb Haemost. 2006 Feb;95(2):393-4. Thromb Haemost. 2006. PMID: 16493504 No abstract available.

6

Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.

Ajjan RA, Grant PJ. Ajjan RA, et al. Diab Vasc Dis Res. 2006 Dec;3(3):147-58. doi: 10.3132/dvdr.2006.023. Diab Vasc Dis Res. 2006. PMID: 17160909 Free article. Review.

7

Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003.

Cubbon RM, Wheatcroft SB, Grant PJ, Gale CP, Barth JH, Sapsford RJ, Ajjan R, Kearney MT, Hall AS; Evaluation of Methods and Management of Acute Coronary Events Investigators. Cubbon RM, et al. Eur Heart J. 2007 Mar;28(5):540-5. doi: 10.1093/eurheartj/ehl510. Epub 2007 Feb 8. Eur Heart J. 2007. PMID: 17289742

8

Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome.

Ajjan R, Carter AM, Somani R, Kain K, Grant PJ. Ajjan R, et al. J Thromb Haemost. 2007 Apr;5(4):754-60. doi: 10.1111/j.1538-7836.2007.02434.x. J Thromb Haemost. 2007. PMID: 17408409 Free article.

9

Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity.

Ajjan R, Lim BC, Standeven KF, Harrand R, Dolling S, Phoenix F, Greaves R, Abou-Saleh RH, Connell S, Smith DA, Weisel JW, Grant PJ, Ariëns RA. Ajjan R, et al. Blood. 2008 Jan 15;111(2):643-50. doi: 10.1182/blood-2007-05-091231. Epub 2007 Oct 9. Blood. 2008. PMID: 17925485 Free article.

10

Aspirin resistance and diabetes mellitus.

Ajjan R, Storey RF, Grant PJ. Ajjan R, et al. Diabetologia. 2008 Mar;51(3):385-90. doi: 10.1007/s00125-007-0898-3. Diabetologia. 2008. PMID: 18197397 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page